Qi Diagnostics Limited is a leading medical device company specializing in proprietary nanosensor technology that detects volatile organic compounds (VOCs) in human breath for health diagnostics. By combining expertise in biochemical sensor development and advanced sensor applications, Qi Diagnostics creates highly sensitive, selective, and non-invasive breathalyzer devices.
The company's flagship product, KetoAir, applies this nanosensor technology to measure ketone levels in the breath, providing users with accurate metabolic health monitoring and support. KetoAir offers a convenient and radiation-free alternative to traditional diagnostic methods, enabling easier management of metabolic conditions such as diabetes and obesity.
Qi Diagnostics is committed to advancing health innovation through biochemical sensor technology and cutting-edge breath analysis, targeting both clinical and consumer health markets globally.
With extensive experience in health innovation and business development, I lead Ketoair as part of Qi Diagnostics Limited, focusing on cutting-edge wellness products tailored for modern lifestyle needs.
My expertise spans product development, market strategy, and cross-border partnerships, aiming to bring effective health solutions to diverse markets.
At the Belt and Road Summit 2025, I seek to engage with investors and collaborators interested in health tech innovation and sustainable growth opportunities.
My commitment is to foster valuable partnerships that enhance product reach and market penetration.